Quarterly Result14 May 2026, 02:21 pm
Senores Pharma Announces FY26 Financial Results
AI Summary
Senores Pharmaceuticals Ltd. has released its audited financial results for the quarter and financial year ended March 31, 2026. The board approved the consolidated and standalone financial results with an unmodified opinion from the statutory auditors, M/s. Pankaj R. Shah and Associates. Additionally, the company announced the resignation of Company Secretary and Compliance Officer, Mr. Vinay Kumar Mishra, effective June 10, 2026, and the appointment of Sharp & Tannan Associates as the Internal Auditor for FY 2026-27.
Key Highlights
- Senores Pharma declares audited financial results for FY26.
- Auditors issue unmodified opinion on FY26 consolidated and standalone statements.
- Vinay Kumar Mishra resigns as Company Secretary, effective June 10, 2026.
- Sharp & Tannan Associates appointed as Internal Auditor for FY27.
Price Impact
More from SENORES